Centro Médico Dra. De Salvo

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension	lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder	Active, not recruiting	Phase 3	2026-10-06		NCT04273945
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis	Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis	Active, not recruiting	Phase 2 / Phase 3	2026-09-28		NCT04033445

Clinical trials